Insider Trading Activity in: Immudyne, Inc. $IMMD

success-1093891_1920

Immudyne, Inc. (IMMD) insider have most recently took part in a trading activity. On Dec 4, 2017 Schreiber Justin, President, Immudyne PR, 10% Owner bought 24,867 shares having total worth of $9,698 at the price of $0.39 per share, following the transaction a total of 3,368,560 shares owned by Schreiber Justin. Before this latest buy, Schreiber Justin purchased IMMD at 2 other times during the past twelve months, for a total investment of $11,607 at an average of $0.42 per share.

The stock has experienced a total of 2 insider trades in the past three months. These trades include 2 buy trades. Furthermore, over the past 12 months , the stock was traded 2 times by insiders. an employee of the company was the buyer in 2 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 2 0 -4.88%
12 Month 2 0 50%

Shares of Immudyne, Inc. (IMMD) traded down 7.14% on Dec 4, 2017, hitting $0.39. 55,850 shares of the company’s stock traded hands. Immudyne, Inc. has a 52 week low of $0.21 and a 52 week high of $0.79. The company’s market cap is $0 million.

Immudyne, Inc., manufacture, distribute and sell natural immune support products. The product of the company include ‘Beta glucans’ which is biological response modifiers that support the immune system.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.